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2The smooth muscle myosin heavy chains  (SMHC) are motor proteins powering 
smooth muscle contraction1-4. Alternate splicing of SHMC gene at the C-terminus 
produces SM1, and SM2 myosin isoforms; SM2 (200 kDa) contains a  unique 9-amino-
acid sequence at the carboxyl terminus, whereas SM1 (204 kDa) has a 43 amino acid 
non-helical tail region5-7.  To date the functional difference between C-terminal isoforms 
has not been established; therefore, we used an exon-specific gene targeting strategy and 
generated a mouse model specifically deficient in SM2. Deletion of exon-41 of the 
SMHC gene resulted in a complete loss of SM2 in homozygous (SM2-/-) mice, 
accompanied by a concomitant down-regulation of SM1 in bladders. While heterozygous 
(SM2+/-) mice appeared normal and fertile, SM2-/- mice died within 30 days after birth. 
The peri-mortal SM2-/- mice showed reduced body weight, distention of the bladder and 
alimentary tract, and end-stage hydronephrosis. Interestingly, strips from SM2-/- bladders 
showed increased contraction to K+ depolarization or M3 receptor activation. These 
results suggest that SM2 myosin has a distinct functional role in smooth muscle, and the 
deficiency of SM2 increases smooth muscle contractility, and causes dysfunctions of 
smooth muscle organs, including the bladder that leads to the end-stage hydronephrosis 
and postnatal death.
We and others have previously shown that alternate splicing of the SMHC gene at 
the N- and C-terminus produces four isoforms (SMA/B, SM1/2) that are restricted to the 
smooth muscle lineage5-8. During embryonic development in mice, SM1 appears early by 
10.5 days post-coitum, whereas SM2 appears late in  fetal development around birth and 
increases steadily during the  postnatal stages; reaching a SM1 to SM2 ratio of 1:1 in 
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3adult stages9. The ratio of SM2:SM1 is both tissue- and species-specific, and is altered 
during disease states; decreased expression of SM2 has been found in primary pulmonary 
hypertension, in neointimal smooth cells of injured or/and atherosclerotic vessels, and in 
obstructive bladder disease10-14.  Studies also suggest that an  alteration in SM2 : SM1 
ratio could modify force development15-18.  In the present study, we used an exon-specific 
gene-targeting strategy to generate a mouse model that is deficient in SM2 but continues 
to express SM1.  To ablate SM2 , exon-41 encoding  nine c-terminal  amino acids, a stop 
signal, along with its flanking 5’and 3’ splicing sequences was replaced with a neomycin-
resistance cassette under the HSV-TK promoter in the  reverse orientation in a targeting 
vector (Fig.1 A). Successful targeting and germ-line transmission was confirmed by long-
distance PCR analyses using primers specific for the wild-type (WT), and mutant alleles 
(data not shown). Both heterozygous (SM2+/-) and homozygous (SM2-/-) pups were 
delivered in an expected Mendelian ratio, which suggests that loss of SM2 does not result 
in embryonic lethality.  
The homozygous newborns had normal body size at birth; however by day 20, the 
SM2-/- mice showed a significant decrease in body weight compared to the SM2+/+ mice 
(8.88 ± 0.35 g vs. 15.61 ± 1.2 g; P < 0.001) and about ~ 50% of the homozygous mice 
died during the first two weeks. Mice that survived beyond two weeks showed 
enlargement of the gastrointestinal system,  distention of the bladder, enlarged kidneys 
(due to development of hydronephrosis)  and retention of urine in the bladder (Fig 1B). 
All homozygous SM2-/- mice died within 4 weeks after birth but the heterozygous mice 
appeared normal and were able to breed. The peri-mortal SM2-/- mice showed severe 
urinary retention in the renal pelvis and bladder body, and developed end-stage 
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4hydronephrosis. We also found that the bladder body of peri-mortal SM2-/- mice was 
significantly enlarged, but its wall thickness was reduced (Fig 1B and C). On the other 
hand, the morphology of the cardiovascular system including aorta and the heart was not 
affected in SM2-/- mice (data not shown).  These results indicate that SM2 is essential for 
the in vivo function of the bladder and alimentary tract. 
To understand the molecular bases for the observed phenotype, we determined if 
protein expression was altered by deletion of the SM2-specific exon. Samples from 
neonate bladders from mice 4-7 days of age, a stage where the SM2-/- bladder was not 
distended, were examined.  Quantitative Western blot analysis showed that SM2 protein 
was absent in SM2-/- bladder as expected and in the SM2+/- bladder, its expression level 
was decreased by 20% (Fig 2A). Also, there was a decrease in the level of SM1 in SM2+/-
and SM2-/- bladder (27% and 56%, respectively; Fig 2A). On the other hand, the levels of 
D-SM-actin and tropomyosin were not altered. Total SMHC protein as assessed by 
Coomassie-blue staining of the gel was decreased by 16% and 62% in SM2+/-, and SM2-/-
bladder, respectively (Fig 2A). However, the SMHC protein band density in aorta was 
very similar between SM2-/- and SM2+/+ mice (Fig 2A), which suggests that the decrease 
in SM1 level in SM2+/- and SM2-/- bladders represents an adaptive response to the loss of 
SM2. Furthermore, electron microscopic examination of the bladder sections showed that 
the overall morphology and structure of smooth muscle cells were similar between null 
and SM2+/+ mice. These results suggest that deletion of the SM2 exon selectively alters 
thick filament proteins, and does not affect the overall smooth muscle cell structure in 
mouse bladder.
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5Next, we determined if the deficiency of SM2 myosin affected smooth muscle 
contraction by examining isometric force development in isolated neonatal bladder 
muscle strips. As shown in Fig 3A, while SM2+/- strips showed responses to K+
comparable with that of SM2+/+ mice, whereas those of SM2-/- mice responded to K+ with 
a significantly increased  sustained-phase of maximal contraction (689 ± 35 mg vs. 242 ± 
26 mg or 84.3 ± 3.0 % vs. 28.4 ± 2.8 % of peak value at 60 mM K+, P< 0.001; Fig 3B) 
and a significantly reduced EC50 (concentration of K+ to reach 50% of maximal 
contraction; 20.4 ± 0.4 vs. 42.9 ± 0.4 mM; P<0.001). Similarly, in response to a sub-
maximal (1 PM) concentration of Carbachol, a selective agonist of the M3 receptor that 
controls physiological bladder emptying, the SM-/- strips also showed significantly 
enhanced contraction (105.6 ± 1.4 % and 74.4 ± 3.8 % vs. 49.3 ± 4.1 % and 27.8 ± 5.0% 
in peak and sustained force, respectively; P<0.001) compared to that of SM+/+ , (Fig 2A). 
These results altogether suggest that the complete loss of SM2 myosin increases smooth 
muscle contractility, whereas a partial loss of SM2 could be compensated in the presence 
of a concomitant decrease in SM1.
To further explore the mechanisms responsible for increased contractility in SM2-
/- bladders, we determined the Ca2+ sensitivity of contractile apparatus in bladder muscle 
strips. As shown in Fig 3B, compared to that of SM+/+ mice, the pCa2+-force relationship 
in E-esin permeabilized SM2-/- strips was significantly shifted to the left (EC50: 0.93 ± 
0.02 vs. 1.70 ± 0.15 PM; P < 0.001; Fig 3B). This result suggests that the loss of SM2 
increases the intrinsic Ca2+ sensitivity of the contractile apparatus. Since phosphorylation 
of the regulatory myosin light chain (MLC20) is the initiator of cross-bridge cycling, and 
normally correlates with the force generation in smooth muscle contraction19, we 
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6determined if this was altered in SM2-/- bladders. To this end, muscle strips were 
stimulated with 40 mM K+, at which a contraction near to maximum was developed in 
SM2-/-, but only 30-40% in SM+/+ mice. As shown in Figure 4, the ratios of 
phosphorylated to total MLC20 both in resting strips and those treated with 40 mM K+
were similar between SM+/+ and SM-/- strips. This result suggests that loss of SM2 does 
not alter the steady state level of MLC20 phosphorylation and as a result, it is most likely 
that the loss of SM2 directly affects the properties of cross-bridge cycling and force 
generation during smooth muscle contraction.   
The above results suggest that SM2 myosin function distinctly from the other 
SHMC isoform, i.e. SM1, and an appropriate ratio of SM1and SM2 myosin is essential 
for the normal contractility of smooth muscle in organs, such as the bladder. In support of 
this idea, the ablation of SMHC gene, ( total loss of SMHC protein ) resulted in a drastic 
decrease of smooth muscle contraction 20. In addition, the loss of SM2 in SM+/- or SM-/-
bladders was accompanied by a concomitant decrease of SM1. SM+/- bladder (despite a 
decrease in SM2) developed comparable force to that of SM+/+ mice. This further 
underscores a unique role for SM2, and suggests that in smooth muscle there exists a 
mechanism to maintain a constant ratio of SM1 and SM2. A recent  study also showed 
that the SM1 and SM2 ratio was not changed by transgenic over-expression of either 
SM1 or SM2; while the transgenic protein was expressed, it was offset by a decrease in 
the levels of  endogenous SM1 or SM2 proteins in the mouse bladder 18.
Also of note is that in the presence of increased smooth muscle contractility, SM2-
/- mice showed urinary retention in bladder or/and the renal pelvis. This might reflect an 
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7increased urinary flow resistance, as observed in obstructive diseases. SM2 has been 
found to be unevenly distributed among smooth muscle tissues. For example, in the 
urethra, SM2 is more abundant than in the bladder21. Thus, it remains to be further 
understood how the ablation of SM2 affects muscle function in the ureter and urethra or 
the functional coordination between organs involved in the in vivo regulation of urinary 
emptying.   
In summary, in this study we generated a mouse model specifically deficient in 
SM2. Our results suggest that SM2 myosin has a distinct function and is necessary for 
overall smooth muscle contractility. Furthermore ablation of SM2 results in 
hypercontractility of smooth muscle but causes dysfunction of smooth muscle organs, 
including the bladder that leads to development of end-stage hydronephrosis and 
postnatal death.
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8Methods
Generation of SM2-deficient mice
Genomic fragment of SM-MHC gene containing the 3’ region (20 kb) was 
isolated from a Ȝ/129 mouse genomic library. Exon 41 and its 5’and 3’ splicing sites (0.4 
kb) were replaced with a neomycin-resistance cassette under the HSV-TK promoter in 
reverse orientation. The linearized construct was electroporated into mouse 129 
embryonic stem cells. Clones resistant to neomycin were screened by long-distance PCR 
with primers specific for the wild type allele and mutant allele. Targeted clones were 
injected into C57BL/6 blast cysts. Chimeric males were mated to B6 females, and the 
germ line transmission of targeted allele was detected by long-distance PCR.  SM2-/-
were obtained by cross-breeding of SM2+/- mice. 
Tissue preparation 
Neonate mice (4-7 days) were used for the experiments. Bladders were isolated 
and cut open, and the mucosa was removed by dissection under a binocular microscope. 
For the functional analyses, muscles from the front wall were cut transversally into 1 mm 
wide and 2 mm long strips. The strips were tied with thread filaments to form a loop at 
both ends separated by a distance of 1 mm. In some experiments the thoracic aortas were 
also isolated and dissected free of adherent tissues for protein analyses. 
Analyses of protein expression 
Protein expression was analyzed with western blot as described elsewhere22.
Briefly, crude myofibril proteins isolated from bladder muscle were separated by 
electrophoresis on SDS-PAGE (5% for SM2 and SM1; 10% for D-actin and tropomyosin; 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
64
3.
1 
: P
os
te
d 
28
 F
eb
 2
00
8
915% for MLC20), and transferred to a nitrocellulose membrane. Proteins were 
sequentially probed with respective first and secondary antibodies. Anti-SM1 and Anti-
SM2 antibodies were kindly provided by Dr. AF Martin and Dr. R Nagai, respectively. 
Anti-D-actin and anti-MLC20 antibodies were purchased from Sigma (St Louis, MO). In 
some experiments, the SDS-PAGE (10%) gels were stained with Coomassie-blue to 
directly visualize both SMHC and actin. Band densities were quantified and analyzed 
with a Biochemi System (UVP, Upland, CA). 
Electron Microscopic examination 
The bladders were expanded in situ and fixed with 4% glutaraldehyde in 0.1M 
phosphate buffer (PH7.2). Strips cut from the treated bladders were further post-fixed in 
2% OsO4 for 2 hrs at room temperature, and contrasted in saturated uranyl acetate for 4 h 
at 60 oC.  Samples were embedded in Epon 812 and cut into sections, which were stained 
with uranyl acetate and lead. Images were detected and photographed with an electron 
microscope (EM 410; Philips Electron Optics, Mahwah, NJ).  
Analysis of intact bladder smooth muscle function 
Muscle strips were attached with the loops to two tungsten wires in an organ bath 
(3 ml) filled with physiological salt solution23(PSS) maintained at 37oC. One wire was 
fixed, and the other was connected to a force transducer (AE801, Holten, Norway). 
Tissues were set at 1.5 times resting length (at which length the contractile response to 60 
mM K+ was maximal and reproducible), and the contractions to the subsequent 10-50 
mM K+ or Carbachol (1 PM) were determined sequentially. Force was expressed as a 
percentage of peak value evoked by 60 mM K+.
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Myofilament Ca2+ sensitivity  
 Muscle strips were attached to the force apparatus as described above, and set at 
to 1.5 times resting length at room temperature. The strips were permeabilized with 50 
PM E-esin (40 min) in Ca2+-free cytosolic substitution solution (CSS24), and treated with 
10 PM A23129 (10 min) in Ca2+-free CSS. After washout, strips were exposed to free 
Ca2+-containing CSS (0.3-10 PM). Force development at each Ca2+ point was expressed 
as a percentage of maximal contraction obtained with 10 PM Ca2+.
Measurement of MLC20 phosphorylation 
Muscle strips (1 x 2 mm2) were placed in 37oC PSS or 40 mM K+ for 5 min and 
the reactions were stopped with 90% acetone, 10% trichloroacetic acid and 10 mM 
dithiothreitol (DTT) chilled at -80oC. Proteins were extracted, separated on Urea/glycerol 
gel (with the amount adjusted to achieve similar total MLC20 content between SM2+/+
and SM2-/- mice), and transferred onto a nitrocellulose membrane as described 
previously24.  Phosphorylated and un-phosphorylated MLC20 were probed with anti-
MLC20 antibody, as in western blot analyses. 
Statistics
For statistical evaluation, values were presented as mean ± SE. Comparison of 
two means was performed by unpaired Student’s t test. Where more than two means were 
compared, 1-way or 2-way ANOVA followed by Dunnett’s or Bonferroni’s post hoc test 
was used. P <0.05 was considered to be statistically significant.
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Figure Legend 
Figure 1: SM2 gene-targeting strategy and mouse phenotype. A: Representation of exon 
41-specific (SM2 isoform-specific) gene targeting. Exon 41 and its flanking sequences 
were replaced with neomycin gene in reverse orientation.  B: Phenotype of SM2-/- mice; 
top: bladder (1), alimentary tract (2) including stomach (3), and the kidney (4) in SM+/+
and SM-/- mice (20 days); Bottom: end-stage hydronephrosis in 25-day SM2-/- and 
kidneys in age-matched SM2+/+ mice, C: Top: comparson of neonatal and peri-mortal 
SM2-/- with age-match SM+/+ bladders. Bottom: microscopic examination of peri-mortal 
SM2-/- and age-matched SM2+/+ bladders. 
Figure 2:  Muscle protein expression and smooth muscle cell structure.  A: top: Western 
blot analyses of SM1 and SM2. Middle: Western blot analyses of a-actin and tropomysin. 
Bottom: Commassie blue staining of gel showing the total SMHC and actin. B:
Morphology and structure of bladder smooth muscle cells detected with electron 
microscopy.      
Figure 3:  Analyses of bladder smooth muscle contractility.   A: Representative traces 
from 5-7 experiments showing the contraction of intact smooth muscle from bladders of 
SM+/+ (blue), SM2+/- (green), or/and SM2-/- (red) mice to 60 mM K+ with subsequent 10-
50 mM K+ (top) or 1 PM Carbachol (bottom).  B: Representative traces (top) and 
summary (bottom) of the responses induced by 0.3 to 10 PM Ca2+ in E-escin (50 PM) 
permeabilized SM+/+ (blue) and SM2-/- (red) strips.
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Figure 4: Detection of phosphorylated and unphosphorylated MLC20 in resting (PSS) 
and 40 mM K+ (K+) stimulated smooth muscle of SM2+/+ (blank bar) and SM-/- (filled bar) 
bladders (n = 4).
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
64
3.
1 
: P
os
te
d 
28
 F
eb
 2
00
8
17
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
64
3.
1 
: P
os
te
d 
28
 F
eb
 2
00
8
18
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
64
3.
1 
: P
os
te
d 
28
 F
eb
 2
00
8
19
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
64
3.
1 
: P
os
te
d 
28
 F
eb
 2
00
8
20
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
64
3.
1 
: P
os
te
d 
28
 F
eb
 2
00
8
21
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
64
3.
1 
: P
os
te
d 
28
 F
eb
 2
00
8
22
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
64
3.
1 
: P
os
te
d 
28
 F
eb
 2
00
8
23
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
64
3.
1 
: P
os
te
d 
28
 F
eb
 2
00
8
24
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
64
3.
1 
: P
os
te
d 
28
 F
eb
 2
00
8
